AeRyon Kim

1.9k total citations
14 papers, 262 citations indexed

About

AeRyon Kim is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, AeRyon Kim has authored 14 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in AeRyon Kim's work include Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (6 papers) and vaccines and immunoinformatics approaches (5 papers). AeRyon Kim is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (6 papers) and vaccines and immunoinformatics approaches (5 papers). AeRyon Kim collaborates with scholars based in United States, South Korea and Spain. AeRyon Kim's co-authors include Scheherazade Sadegh‐Nasseri, Isamu Z. Hartman, Tatiana Boronina, Robert N. Cole, Rachel R Caspi, Marion Ciudad, Brad Poore, Dolores Jaraquemada, Wendell P. Griffith and Sarat K. Dalai and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Medicine and Nature Communications.

In The Last Decade

AeRyon Kim

12 papers receiving 259 citations

Peers

Countries citing papers authored by AeRyon Kim

Since Specialization

Citations

This map shows the geographic impact of AeRyon Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AeRyon Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AeRyon Kim more than expected).

Fields of papers citing papers by AeRyon Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AeRyon Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AeRyon Kim. The network helps show where AeRyon Kim may publish in the future.

Co-authorship network of co-authors of AeRyon Kim

This figure shows the co-authorship network connecting the top 25 collaborators of AeRyon Kim. A scholar is included among the top collaborators of AeRyon Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AeRyon Kim. AeRyon Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Stereoselective Degradation of Diacylglycerol Kinases Potentiate T cell Activation and Tumor Cell Cytotoxicity 2025 ·bioRxiv (Cold Spring Harbor Laboratory) ·(unknown), Saktipada Mookherjee, (unknown), Adam H. Libby, Aizhen Xiao, Yunge Zhao, (unknown), AeRyon Kim, Zhihong Li, (unknown), (unknown), (unknown), (unknown), Timothy N. J. Bullock, Benjamin Purow, Gerald Hammond, Ken Y. Hsu	0
2	A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design 2023 ·The Journal of Experimental Medicine ·Srona Sengupta, (unknown), (unknown), (unknown), AeRyon Kim, Tatiana Boronina, (unknown), James O. Wrabl, Kevin Shenderov, (unknown), Weiming Yang, Andrew E. Timmons, Rebecca Hoh, Robert N. Cole, Steven G. Deeks, Janet D. Siliciano, Robert F. Siliciano, Scheherazade Sadegh‐Nasseri	3
3	Studying MHC Class II Peptide Loading and Editing In Vitro 2019 ·Methods in molecular biology ·AeRyon Kim, Isabel E. Ishizuka, Isamu Z. Hartman, (unknown), Kedar Narayan, Scheherazade Sadegh‐Nasseri	1
4	LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells 2019 ·The Journal of Immunology ·AeRyon Kim, (unknown), Ian Driver, Aleksandra Olow, Andrew K. Sewell, Zemin Zhang, Wenjun Ouyang, Jackson G. Egen, Xin Yu	34
5	Oscarellin, an Anthranilic Acid Derivative from a Philippine Sponge, Oscarella stillans, as an Inhibitor of Inflammatory Cytokines in Macrophages 2017 ·Journal of Natural Products ·(unknown), (unknown), Suhkneung Pyo, (unknown), AeRyon Kim, Francis J. Schmitz	15
6	Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis 2016 ·Journal of Proteome Research ·Erika Darrah, AeRyon Kim, Xi Zhang, Tatiana Boronina, Robert N. Cole, Andrea Fava, Jon T. Giles, Clifton O. Bingham, Michael J. Chalmers, Patrick R. Griffin, Scheherazade Sadegh‐Nasseri, Antony Rosen	27
7	Exploring a possible role for the MHC Class II accessory molecule H2-O in the development of experimental autoimmune encephalomyelitis 2016 ·The Journal of Immunology ·(unknown), (unknown), AeRyon Kim, (unknown), Scheherazade Sadegh‐Nasseri	1
8	Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources 2014 ·Nature Communications ·AeRyon Kim, Isamu Z. Hartman, Brad Poore, Tatiana Boronina, Robert N. Cole, (unknown), Marion Ciudad, Rachel R Caspi, Dolores Jaraquemada, Scheherazade Sadegh‐Nasseri	50
9	Multiple paths to immunodominance: dominant epitopes are captured by MHC II prior, or post antigen proteolysis, and are enriched by HLA-DM (APP2P.103) 2014 ·The Journal of Immunology ·Scheherazade Sadegh‐Nasseri, AeRyon Kim, Isamu Z. Hartman, (unknown), (unknown), Tatiana Boronina, Rachel R Caspi, Dolores Jaraquemada	0
10	Mix to Validate: A Facile, Reversible PEGylation for Fast Screening of Potential Therapeutic Proteins In Vivo 2013 ·Angewandte Chemie International Edition ·Tae Hyung Kim, Magdalena Swierczewska, Yumin Oh, AeRyon Kim, Dong‐Gyu Jo, Jae Hyung Park, Youngro Byun, Scheherazade Sadegh‐Nasseri, Martin G. Pomper, Kang Choon Lee, Seulki Lee	27
11	HLA-DO and Its Role in MHC Class II Antigen Presentation 2013 ·Frontiers in Immunology ·(unknown), AeRyon Kim, Scheherazade Sadegh‐Nasseri	31
12	Mix to Validate: A Facile, Reversible PEGylation for Fast Screening of Potential Therapeutic Proteins In Vivo 2013 ·Angewandte Chemie ·Tae Hyung Kim, Magdalena Swierczewska, Yumin Oh, AeRyon Kim, Dong‐Gyu Jo, Jae Hyung Park, Youngro Byun, Scheherazade Sadegh‐Nasseri, Martin G. Pomper, Kang Choon Lee, Seulki Lee	3
13	Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection 2010 ·Immunologic Research ·Scheherazade Sadegh‐Nasseri, (unknown), Chih-Ling Chou, Isamu Z. Hartman, Kedar Narayan, AeRyon Kim	23
14	A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes 2010 ·Nature Medicine ·Isamu Z. Hartman, AeRyon Kim, Robert J. Cotter, Kimberly Walter, Sarat K. Dalai, Tatiana Boronina, Wendell P. Griffith, David E. Lanar, Robert Schwenk, Urszula Krzych, Robert N. Cole, Scheherazade Sadegh‐Nasseri	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact